When front-line treatments for pediatric cancer are not responsive, the Developmental Therapeutics Program at Children's Health offers new, promising medicines and treatment methods before they are more widely available. 

The specialists and sub-specialists in our program are recognized across the country and the world for their outstanding care and leading research. They provide the treatments and extensive support your family needs for cases of:

• Refractory cancer: The cancer does not respond to established therapies, either showing resistance right away or developing it during the course of treatment.

• Relapsed cancer: Treatment initially improves your child’s condition, but then the disease returns